JW Pharmaceutical Corporation
Symbol: 001060.KS
KSC
30750
KRWDzisiejsza cena rynkowa
18.7613
Wskaźnik P/E
0.2072
Wskaźnik PEG
707.11B
Kapitalizacja MRK
- 0.01%
Rentowność DIV
JW Pharmaceutical Corporation (001060-KS) Sprawozdania finansowe
Bilans
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 369240.03 | 92838 | 149678.7 | 65666.1 | |||||||||||||||||
balance-sheet.row.short-term-investments | 280726.91 | 76929.2 | 115780.8 | 32299.6 | |||||||||||||||||
balance-sheet.row.net-receivables | 689190.07 | 173629.3 | 162146.2 | 192840 | |||||||||||||||||
balance-sheet.row.inventory | 456503.25 | 106091.4 | 111668.4 | 102527.6 | |||||||||||||||||
balance-sheet.row.other-current-assets | 15865.72 | 5532.7 | 1963.7 | 5417.8 | |||||||||||||||||
balance-sheet.row.total-current-assets | 1530799.07 | 378091.4 | 425457.1 | 366451.5 | |||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 624681 | 155723.7 | 123048.1 | 118392.3 | |||||||||||||||||
balance-sheet.row.goodwill | 11794.82 | 1404.5 | 0 | 0 | |||||||||||||||||
balance-sheet.row.intangible-assets | 96046.76 | 28952 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 104378.13 | 30356.4 | 16266.2 | 21473.1 | |||||||||||||||||
balance-sheet.row.long-term-investments | 74489.66 | 52498.2 | -81554 | 69814.7 | |||||||||||||||||
balance-sheet.row.tax-assets | 89655.86 | 20623.3 | 21811.3 | 20802.2 | |||||||||||||||||
balance-sheet.row.other-non-current-assets | 207068.03 | 7745.9 | 122944.1 | 36119.4 | |||||||||||||||||
balance-sheet.row.total-non-current-assets | 1100272.68 | 266947.4 | 202515.7 | 266601.6 | |||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.total-assets | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.account-payables | 262951.71 | 73847.2 | 82907.9 | 51642.9 | |||||||||||||||||
balance-sheet.row.short-term-debt | 667547.61 | 117404.6 | 207693 | 123074.6 | |||||||||||||||||
balance-sheet.row.tax-payables | 52523.03 | 11113.5 | 13983.9 | 29008.6 | |||||||||||||||||
balance-sheet.row.long-term-debt-total | 173876.69 | 30000 | 1849.3 | 122070.1 | |||||||||||||||||
Deferred Revenue Non Current | 1431.95 | 1325.4 | 0 | -13199.8 | |||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 5294.44 | - | - | - | |||||||||||||||||
balance-sheet.row.other-current-liab | 298716.84 | 89585.4 | 82814.9 | 35045.6 | |||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 309778.22 | 92671.2 | 22082.6 | 161836 | |||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||||
balance-sheet.row.capital-lease-obligations | 107834.96 | 22875.8 | 3102.6 | 2600.9 | |||||||||||||||||
balance-sheet.row.total-liab | 1624750.34 | 379598.3 | 402213.7 | 444513.6 | |||||||||||||||||
balance-sheet.row.preferred-stock | 14694.66 | 3173.6 | 3973 | 3352.6 | |||||||||||||||||
balance-sheet.row.common-stock | 229703.46 | 57925.9 | 55445.2 | 53849.8 | |||||||||||||||||
balance-sheet.row.retained-earnings | 370663.26 | 92612 | 89129.8 | 58594.7 | |||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 82131.39 | 53896.2 | 51771.8 | 52070.7 | |||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 323844.34 | 57832.7 | 40034.3 | 33327 | |||||||||||||||||
balance-sheet.row.total-stockholders-equity | 1021037.11 | 265440.5 | 240354.1 | 201194.8 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2631071.75 | 645038.8 | 627972.8 | 633053.1 | |||||||||||||||||
balance-sheet.row.minority-interest | -14715.71 | 0 | -14595.1 | -12655.2 | |||||||||||||||||
balance-sheet.row.total-equity | 1006321.4 | 265440.5 | 225759 | 188539.5 | |||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2631071.75 | - | - | - | |||||||||||||||||
Total Investments | 355216.57 | 129427.3 | 34226.8 | 102114.3 | |||||||||||||||||
balance-sheet.row.total-debt | 887720.78 | 170280.4 | 209542.3 | 245144.7 | |||||||||||||||||
balance-sheet.row.net-debt | 799207.66 | 154371.6 | 175644.4 | 211778.2 |
Rachunek przepływów pieniężnych
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 37151.21 | 35096 | 29852.6 | -1441.5 | |||||||||||||||||
cash-flows.row.depreciation-and-amortization | 22574.6 | 22444.6 | 16836.3 | 16111.7 | |||||||||||||||||
cash-flows.row.deferred-income-tax | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.change-in-working-capital | -20262.51 | -20262.5 | -6169.7 | -46055.8 | |||||||||||||||||
cash-flows.row.account-receivables | -3162.23 | -3162.2 | -4352.5 | -41296.6 | |||||||||||||||||
cash-flows.row.inventory | 8916.8 | 8916.8 | -11541.3 | -2655.1 | |||||||||||||||||
cash-flows.row.account-payables | -9535.56 | -9535.6 | 31652.3 | 3729.7 | |||||||||||||||||
cash-flows.row.other-working-capital | -16481.52 | -16481.5 | -21928.1 | -5833.7 | |||||||||||||||||
cash-flows.row.other-non-cash-items | 47693.94 | 49879.1 | 16245.2 | 49509.5 | |||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 87157.24 | 0 | 0 | 0 | |||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.acquisitions-net | -14325.59 | -12034 | -40.9 | 385 | |||||||||||||||||
cash-flows.row.purchases-of-investments | -61344 | -61344 | -73817.4 | -140023.5 | |||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 69604.03 | 69604 | 47473.7 | 141101.7 | |||||||||||||||||
cash-flows.row.other-investing-activites | -19152.8 | -17093.1 | 19817.9 | -11430.8 | |||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | -63780.27 | -63834.3 | -18919.2 | -22869.2 | |||||||||||||||||
cash-flows.row.debt-repayment | -216351.12 | -28189.8 | -177004.4 | -98658.1 | |||||||||||||||||
cash-flows.row.common-stock-issued | 7880.94 | -3873 | 10000 | 398.5 | |||||||||||||||||
cash-flows.row.common-stock-repurchased | -260.87 | -260.9 | -281.6 | -412.3 | |||||||||||||||||
cash-flows.row.dividends-paid | 0 | -8813.7 | -7352 | -7149.5 | |||||||||||||||||
cash-flows.row.other-financing-activites | 176299.39 | -54 | 137730.5 | 133023 | |||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -41245.33 | -41191.3 | -36907.5 | 27201.6 | |||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | -120.69 | -120.7 | -406.4 | 458.7 | |||||||||||||||||
cash-flows.row.net-change-in-cash | -17989.06 | -17989.1 | 531.4 | 22915.1 | |||||||||||||||||
cash-flows.row.cash-at-end-of-period | 88513.13 | 15908.9 | 33897.9 | 33366.5 | |||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 106502.18 | 33897.9 | 33366.5 | 10451.3 | |||||||||||||||||
cash-flows.row.operating-cash-flow | 87157.24 | 87157.2 | 56764.4 | 18124 | |||||||||||||||||
cash-flows.row.capital-expenditure | -38561.91 | -42967.2 | -12352.5 | -12901.6 | |||||||||||||||||
cash-flows.row.free-cash-flow | 48595.33 | 44190 | 44411.9 | 5222.4 |
Wiersz rachunku zysków i strat
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 748526.71 | 748526.7 | 684351.1 | 606584.9 | |||||||||||||||||
income-statement-row.row.cost-of-revenue | 412984.31 | 412854.3 | 396396.6 | 372208.6 | |||||||||||||||||
income-statement-row.row.gross-profit | 335542.4 | 335672.4 | 287954.5 | 234376.3 | |||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||
income-statement-row.row.research-development | 33671.36 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-general-administrative | 204703.62 | - | - | - | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.other-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.operating-expenses | -2317.17 | 238911.4 | 225175.5 | 203176.5 | |||||||||||||||||
income-statement-row.row.cost-and-expenses | 474255.45 | 651765.7 | 621572 | 575385.1 | |||||||||||||||||
income-statement-row.row.interest-income | 5893.15 | 5893.1 | 5321.5 | 1654.8 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 35443.42 | - | - | - | |||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||
income-statement-row.row.other-operating-expenses | -253431.49 | -36136.8 | 64701.4 | 67954.7 | |||||||||||||||||
income-statement-row.row.total-operating-expenses | -45650.78 | -42545.6 | -17598.9 | -10667.2 | |||||||||||||||||
income-statement-row.row.interest-expense | 9617.04 | 12561.7 | 9386.8 | 7336.7 | |||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 179363.79 | 22444.6 | 19571.5 | 16180.7 | |||||||||||||||||
income-statement-row.row.ebitda-caps | 279325.21 | - | - | - | |||||||||||||||||
income-statement-row.row.operating-income | 99961.42 | 96761 | 62960.9 | 31199.8 | |||||||||||||||||
income-statement-row.row.income-before-tax | 54310.64 | 54215.4 | 45362 | 20532.7 | |||||||||||||||||
income-statement-row.row.income-tax-expense | 16406.19 | 16406.2 | 15509.4 | 21974.1 | |||||||||||||||||
income-statement-row.row.net-income | 37006.33 | 37006.3 | 31891.7 | -1441.5 |
Często zadawane pytania
Ile wynosi JW Pharmaceutical Corporation (001060.KS) aktywów ogółem?
JW Pharmaceutical Corporation (001060.KS) całkowite aktywa to 645038796101.000.
Jaki jest roczny przychód przedsiębiorstwa?
Roczny przychód to 389220837356.000.
Jaka jest marża zysku firmy?
Marża zysku firmy to 0.448.
Czym są wolne przepływy pieniężne firmy?
Wolne przepływy pieniężne to 2124.292.
Jaka jest marża zysku netto przedsiębiorstwa?
Marża zysku netto to 0.049.
Jaki jest całkowity przychód firmy?
Całkowity przychód to 0.134.
Co to jest JW Pharmaceutical Corporation (001060.KS) zysk netto (dochód netto)?
Zysk netto (dochód netto) wynosi 37006333990.000.
Jakie jest całkowite zadłużenie firmy?
Całkowite zadłużenie to 170280439662.000.
Ile wynoszą koszty operacyjne?
Wydatki operacyjne to 238911370958.000.
Jaka jest wartość gotówki firmy?
Środki pieniężne przedsiębiorstwa to 15908868301.000.